Here we present the crystal structure of a complex between the gp120 protein from the clade C virus CAP210.2.00.E8 and compare the CAP210 gp120 to known clade B gp120 structures [3] [4] [5] [6] [7] [8] . We also describe the potential for autoreactivity by the 21c antibody revealed by the CAP210-sCD4-21c structure, which shows that 21c has a bimolecular epitope involving the expected contacts with gp120 as well as unexpected contacts with sCD4. Binding studies verify the 21c contact with sCD4, showing that 21c can bind sCD4 in the absence of gp120 and that the antibody binds CAP210, other clade C gp120s and an HIV-2 gp120 only when the Fab can form the crystallographically observed contacts with sCD4. To explore the mechanism for the poor clade C neutralization potency of 21c 14 , we compared binding of the 21c Fab to gp120s including or not including the V1V2 domain, deriving results suggesting that the V1V2 loop generally blocks 21c access to gp120s, even in the presence of sCD4. The crystal structure and binding studies presented here suggest an additional mechanism for the CD4 dependence of 21c-like CD4i antibodies-direct contacts with CD4 in a gp120-CD4-CD4i antibody complex-in addition to demonstrating the potential for autoreactivity by 21c and other CD4i antibodies.
Here we present the crystal structure of a complex between the gp120 protein from the clade C virus CAP210.2.00.E8 and compare the CAP210 gp120 to known clade B gp120 structures [3] [4] [5] [6] [7] [8] . We also describe the potential for autoreactivity by the 21c antibody revealed by the CAP210-sCD4-21c structure, which shows that 21c has a bimolecular epitope involving the expected contacts with gp120 as well as unexpected contacts with sCD4. Binding studies verify the 21c contact with sCD4, showing that 21c can bind sCD4 in the absence of gp120 and that the antibody binds CAP210, other clade C gp120s and an HIV-2 gp120 only when the Fab can form the crystallographically observed contacts with sCD4. To explore the mechanism for the poor clade C neutralization potency of 21c 14 , we compared binding of the 21c Fab to gp120s including or not including the V1V2 domain, deriving results suggesting that the V1V2 loop generally blocks 21c access to gp120s, even in the presence of sCD4. The crystal structure and binding studies presented here suggest an additional mechanism for the CD4 dependence of 21c-like CD4i antibodies-direct contacts with CD4 in a gp120-CD4-CD4i antibody complex-in addition to demonstrating the potential for autoreactivity by 21c and other CD4i antibodies.
RESULTS

Overview of the CAP210-sCD4-21c complex structure
To obtain a clade C gp120 structure, we screened 21 clade C gp120s combined with Fabs from 6 anti-gp120 antibodies and/or with sCD4 (domains 1 and 2 from human CD4). We modified gp120s by eliminating conserved but nonessential N-linked glycosylation sites 15 . In addition, we truncated the V1V2 and V3 loops and the N and C termini of the proteins similarly to constructs used for crystallization of clade B gp120s 6 . We obtained crystals for several different combinations, most involving HIV/AIDS has a disproportionate effect in the developing world, where AIDS has devastated entire countries, especially in sub-Saharan Africa 1 . Group M HIV-1, which is responsible for the majority of infections worldwide, is divided into ten clades, of which clade C is the most abundant subtype in countries with the most HIV-1 infections and in Africa specifically 2 . High-resolution structural information concerning the envelope spike that mediates binding to host receptors (CD4 and a chemokine receptor) as well as fusion of viral and cellular membranes was limited to structures of gp120 monomers derived from North American and Western European clade B viruses [3] [4] [5] [6] [7] [8] and simian immunodeficiency virus 9 . Many of these structures involved ternary complexes between a clade B gp120, soluble CD4 (sCD4) and a CD4-induced (CD4i) antibody [3] [4] [5] [6] .
CD4i antibodies recognize conserved regions of gp120 at or near the binding site for the host co-receptor (the CCR5 or CXCR4 chemokine receptor), regions that are exposed by a conformational change caused by CD4 binding 10 . These antibodies are often cross-reactive but are not very potent due to limited steric accessibility when gp120 on the viral membrane is bound to CD4 on the target cell 11 . However, some CD4i antibodies show reactivity toward free gp120, although less than that toward CD4-gp120 complexes, suggesting that unliganded envelope spikes sample different conformations, including the CD4-bound conformation 10 . The 21c CD4i antibody, which shows little binding to free gp120s (R.D. and P.J.B., unpublished data), was isolated from transformed B cells donated by a HIV-1 infected individual classified as a long-term nonprogressor 12 . Although HIV-1 and HIV-2 generally share only weak antigenic cross-reactivity, 21c and other CD4i antibodies found in the sera of HIV-1-infected patients neutralized HIV-2 as well as HIV-1 viruses in the presence of soluble CD4 (sCD4) 13 .
Comparison of clade B and C gp120 structures
The overall structure of the core clade C CAP210 gp120 is similar to the core structures of HXBc2, YU2 and JR-FL clade B gp120s 3, 4, 6 , with r.m.s. deviations of 0.9 Å, 1.1 Å and 1.0 Å for superpositions of 268, 263, and 266 common carbon-α atoms, respectively. However, the core clade C CAP210 gp120 structure is somewhat more different from clade B structures than they are from each other, with r.m.s. deviations of 0.7 Å (HXBc2 and YU2; 267 carbon-α atoms), 0.8 Å (HXBc2 and JR-FL; 272 carbon-α atoms) and 0.8 Å (YU2 and JR-FL; 278 carbon-α atoms) (Fig. 3) . CD4-bound gp120s share a heart-shaped structure consisting of the inner and outer domains with a bridging sheet at the base of the heart 6 (Fig. 1b) . The N and C termini of the polypeptide chain are in the inner domain, distal to the bridging sheet. The co-receptor-CD4i Fab binding site is located on the bridging sheet 3 , and the CD4 binding site is located between the inner and outer domains and is restricted by the CD4-binding loop 7, 16 . Five hypervariable regions, V1-V5, decorate the surface of gp120, forming extended loops 6 (Fig. 1b) . The loops mask conserved regions that form the CD4 and the chemokine receptor binding sites and, in the case of the V3 loop, determine cell tropism of the virus through interactions with the co-receptor 17, 18 . The first variable region in the CAP210 construct is V4, a 26-residue loop of which 21 residues (Thr392-Asn412) are disordered. This region is also disordered in the HXBc2 and YU2 structures 3, 6 (21 and 13 residues, respectively) but is ordered in the structure of JR-FL 4 (17 residues). The CAP210 V5 region is a nine-residue loop, three residues longer than V5 in clade B gp120s, and it includes two potential N-linked glycosylation sites, as compared with one in clade B sequences (Supplementary Fig. 1) .
The CD4-binding loop, which interacts with D1 of CD4 and forms a central part of the epitope for b12 and other antibodies that target the CD4 binding site 7, 8, 16 , differs in conformation between CAP210 and clade B gp120s (Fig. 3) . Sequence variations at the base of this loop facilitate resistance to neutralization by b12 (ref. 16 ). CAP210 Leu363, conserved in all clade C strains, replaces Pro369, found in most clade B gp120s (Supplementary Fig. 1 ). The Leu363 side chain extends from the loop in a manner proposed to interfere with b12 binding, consistent with the low potency of b12 in neutralization of CAP210 HIV-1 (ref. 16) . Another difference is the replacement of Ser364, common in clade B gp120s, with Pro358 in CAP210. This substitution, also in other clade C gp120s, is not correlated with escape from b12 neutralization but may promote additional flexibility in clade C CD4-binding loops due to loss of a stabilizing intraloop hydrogen bond in clade B loops between the Ser364 side chain and the main chain NH group of Gly366 (Fig. 3) . In common with clade B a complex between a clade C gp120, sCD4 and the Fab from the CD4i antibody 21c 12 . We obtained crystals suitable for data collection from a complex containing the clade C CAP210 gp120, and we solved the structure of CAP210-sCD4-21c to 3.4-Å resolution ( Table 1) . We also solved the structure of the uncomplexed 21c Fab to 2.2-Å resolution.
As seen in previously described clade B gp120-sCD4-CD4i Fab structures (HXBc2-sCD4-17b, YU2-sCD4-17b, YU2-sCD4-412d and JR-FL-sCD4-X5) [3] [4] [5] [6] , the CAP210-sCD4-21c structure comprises the globular core gp120, domains 1 and 2 of CD4 and the variable heavy (V H ), variable light (V L ), constant heavy (C H 1) and constant light (C L ) domains of a CD4i Fab (Fig. 1) . As in the other structures, sCD4 binds to CAP210 gp120 mainly using the C′′ β-strand of its domain 1, burying ~1,100 Å 2 of sCD4 surface area, with a gap between the D1 C′ strand and the gp120 surface (Fig. 2) . Comparison of gp120-sCD4-CD4i Fab structures shows that CD4i Fabs adopt different orientations, with the light chains of the 21c and X5 Fabs facing sCD4, whereas the heavy chains of the 17b and 412d Fabs are closest to sCD4 (Fig. 1c) . Values in parentheses are for highest-resolution shell; 5% of unique reflections were removed as a test set for the R free calculation.
a r t i c l e s
Although different CD4i antibodies target distinct regions of the chemokine receptor binding site on gp120, 21c is the first CD4i antibody also observed to make direct contacts with CD4 (Fig. 1c) (a total of 750 Å 2 of buried surface area at the 21c-sCD4 interface). On sCD4, the interface includes residues from the loops between β-strands A and B and between strands E and F and a short (five-or six-residue) helical segment preceding strand D, which deviates from ideal β-strand dihedral angles (Fig. 2a) . On 21c, the interface maps mainly to the light chain (L1 and a nearby framework region between 21c β-strands D and E) plus three residues from H3 ( Fig. 4a,b) . Important contacts include an ionic interaction between 21c L1 residue Lys32 and sCD4 D1 residue Asp53 as well as framework residue Ser69 contacting sCD4 near Asp10 in a possible hydrogen bond network involving main chain atoms (Supplementary Fig. 3b ). The 21c H3 loop that contacts gp120 also contributes the sCD4 interface: for example, H3 Leu105 is stabilized in a pocket created by CAP210 and sCD4 Arg59 and Ser60, thus contacting both sCD4 and gp120. In addition, the 21c H3 Trp106 side chain, although disordered, projects toward sCD4 and contributes to the interface, whereas the main chain contacts gp120.
Comparison of bound and free 21c structures
We compared the structures of free and complexed 21c Fab by superimposing the variable domains ( Supplementary Fig. 4) . The most obvious difference is the relative orientation of the V H -V L and C H 1-C L gp120s, CAP210 Asp362 interacts with sCD4 Arg59, an interaction mimicked by some anti-CD4 binding site antibodies 8 .
The bimolecular epitope of 21c
Contacts between 21c and CAP210 map exclusively to the antibody heavy chain, as also observed in a b12-HXBc2 complex structure 7 . The gp120 footprint on 21c involves the H2 and H3 complementaritydetermining regions (CDRs) plus a framework loop connecting β-strands D and E (Fig. 4 and Supplementary Fig. 2 ), which interact with the CAP210 bridging sheet and the base of the V1V2 stem, burying a total of 1,290 Å 2 at the 21c-gp120 interface. Important interactions include Leu105 from the 21c H3 loop anchored in a hydrophobic pocket at the base of V1V2 defined by CAP210 residue Pro123, and a salt bridge between 21c H2 residue Glu55 and CAP210 Arg431. In addition, Glu54 and Asn56 from the 21c H2 loop are in close proximity to two CAP210 arginines (Arg420 and Arg418), likely forming a hydrogen bond network together with solvent molecules (we did not observe ordered water molecules due to resolution limitations), and a portion of the 21c framework region near Thr74 buries CAP210 Met433 and Cys118 (Supplementary Fig. 3a) . 
D1 (green ribbons with letters referring to individual β-strands, blue highlights for 21c-contacting regions, and pink highlights for CAP210-contacting regions), CAP210 gp120 (gray) and the 21c heavy and light chains (pink and yellow, respectively). The sCD4 C′ strand is near the interface with gp120 but forms no contacts within 1.4 Å, creating a gap at the sCD4-gp120 interface as seen in previous structures 3, 4, 6 . (b) Surface representations of sCD4 from different gp120-sCD4-CD4i Fab structures (PDB 1G9M, 2QAD and 2B4C for HXBc2-sCD4-17b 5 , YU2-sCD4-412d 3 and JR-FL-sCD4-X5 (ref. 4) , respectively). sCD4 surface area buried at the interface with gp120 is highlighted in pink, with the area in Å 2 indicated. The CAP210-sCD4-21c structure is the only complex structure in which the CD4i Fab also contacts sCD4 (blue highlighted area). Fig. 1 ) may restrict access to the CD4 binding site.
The contact between sCD4 and the 21c V L domain in the CAP210-sCD4-21c structure prompted us to investigate whether 21c binds to CD4 in the absence of gp120. For comparison with wild-type sCD4, we constructed a sCD4 mutant (sCD4 K75T ) in which we introduced an N-linked glycosylation site in a position predicted to interfere with sCD4 interactions with 21c but not with gp120 (Fig. 5a) . SDS-PAGE analysis showed a mobility shift consistent with glycosylation of the introduced Asn-X-Thr motif (Fig. 5b) , and a surface plasmon resonance (SPR) binding assay verified that sCD4 K75T retained binding to CAP210 gp120 (data not shown). SPR experiments in which we injected increasing concentrations of sCD4 or sCD4 K75T over immobilized 21c Fab revealed weak binding for the sCD4-21c interaction (K D >100 µM) but no detectable binding of sCD4 K75T or CAP210 core gp120 to 21c (Fig. 5c) . These results show that 21c Fab binds to sCD4 in the absence of gp120 using the crystallographically observed contacts and that 21c requires sCD4 for binding to CAP210 gp120.
21c contacts sCD4 in clade C and HIV-2 gp120 complexes
To investigate whether the 21c contact with sCD4 is a general characteristic of its interactions with gp120-sCD4 complexes or results from special features related to CAP210, we compared the abilities domain pairs. Compared with complexed 21c, the heavy chain of the free Fab adopts a more acute elbow-bend angle between the V H and C H 1 domains and a concomitant increase in the bend angle between the V L and C L domains, resulting in an ~31-Å movement of the constant domains. The changes, likely resulting from different crystal-packing forces, show the potential for interdomain flexibility during binding of the 21c IgG to HIV or virally infected cells. The largest binding-induced changes are in the H3 and H2 loops, which adopt new conformations that allow Leu105 (H3) and Glu55 (H2) to fit into their respective pockets on gp120. K75T . The introduced glycan is predicted to disrupt interactions with 21c but is distant from the interface with gp120. (b) SDS-PAGE comparison of the mobility of wild-type sCD4 and sCD4 K75T . The mobility shift to a higher apparent molecular weight of sCD4 K75T compared with sCD4 is consistent with glycosylation at the introduced N-linked glycosylation site. (c) Equilibrium binding data (equilibrium binding response (R eq )) versus the log of the indicated protein concentrations) for SPR experiments in which sCD4, sCD4 K75T , or CAP210 gp120 were injected over immobilized 21c. The best-fit binding curve to the experimental data is shown for the sCD4-21c interaction. (d) Sensorgrams from SPR experiments in which a concentration series (1.0 µM-31.2 nM, two-fold dilutions) of the indicated core gp120 protein (clade C CAP210 or HIV-2 UC1) was injected together with 2 µM sCD4 (orange curves) or sCD4 K75T (blue curves, thickened for clarity) over immobilized 21c Fab (reproduced with residual plots in Supplementary Fig. 5) . (e) Sensorgrams from SPR experiments in which a concentration series (1.0 µM-31.2 nM, two-fold dilutions) of the indicated gp120 protein containing the V1V2 loop (CAP210 V1V2 or UC1 full-length ) was injected together with 2 µM sCD4 (orange curves) or sCD4 K75T (blue curves) over immobilized 21c Fab (reproduced with residual plots in Supplementary Fig. 5 ). a r t i c l e s to the membrane-proximal region (MPER) of the gp41 subunit of the HIV-1 envelope spike [22] [23] [24] . Analogous to our finding that distinct surfaces of the 21c Fab bind to sCD4 and to gp120 (Fig. 4b) , 4E10 binds to lipids using one region of its H3 loop and to gp41 using another region of H3 (ref. 25) . Although anti-MPER antibodies bind only weakly to lipids alone 25, 26 , a recent study showed that 2F5 is sufficiently autoreactive to activate immunological tolerance in a knock-in mouse 27 , raising the possibility that the weak affinity we observed for 21c Fab binding to sCD4 (Fig. 5c) is also physiologically relevant.
Potential origins of 21c-like antibodies
The bimolecular nature of the 21c epitope raises intriguing questions about the origins of antibodies like 21c, which show both self and nonself reactivity. One possibility is that the 21c heavy chain was selected to recognize gp120, and the light chain by chance interacted weakly with CD4 in the orientation imposed by the 21c-gp120 interaction. A chance interaction seems unlikely, however, given that one of the L1 residues that contacts sCD4 (Lys32) was induced by somatic mutation from the germline sequence (Supplementary Fig. 2 ). If self-reactive binding was selected, 21c-like autoreactive antibodies would likely be found only at relatively late stages in a HIV infection, after dysregulation of the host immune system. By analogy to the possibility that anti-MPER antibodies were originally generated by a combination of virion lipids and the HIV-1 envelope spike, the 21c epitope might be created by gp120-CD4 complexes, generated by free gp120 binding to CD4 on T cells, by CD4 fragments released after necrotic death of infected T cells binding to a virus or released gp120, or by membrane-bound CD4-gp120 complexes on infected T cells. 
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Published online at http://www.nature.com/nsmb/. Reprints and permissions information is available online at http://npg.nature.com/ reprintsandpermissions/. of sCD4 and sCD4 K75T to form gp120-sCD4-21c complexes. The binding of 21c to the CAP210-sCD4 K75T complex was greatly reduced compared to that of the CAP210-sCD4 complex (Fig. 5d) , verifying that the crystallographically observed 21c contacts with sCD4 occur when 21c binds to CAP210 in solution. We observed similar results for a comparison of the interactions of sCD4 and sCD4 K75T with 21c and the core regions of the two other clade C gp120s (Supplementary Fig. 5 ) and UC1, a gp120 from a HIV-2 strain that is potently neutralized by 21c plus sCD4 (ref. 13) (Fig. 5d) .
The role of V1V2 in masking the 21c epitope Several conformational changes in gp120 occur after CD4 binding 9 . One involves the movement of V1V2 to expose the co-receptor binding site and reveal epitopes for CD4i antibodies. Intact IgG forms of CD4i antibodies are often less potent for neutralization than their Fab or single-chain fragment variable (scFv) counterparts due to steric occlusion of the larger IgGs when the CD4i epitope is exposed in the small volume between the viral and host cell membranes 11 . Indeed, 21c IgG does not neutralize CAP210 HIV-1 (ref. 14). However, the 21c Fab, alone or with added sCD4, also fails to neutralize CAP210 (data not shown), although 21c plus sCD4 binds to core CAP210 gp120. To evaluate the role of variable loops that are missing from the core CAP210 construct in binding to nontruncated envelope spikes, we expressed core CAP210 gp120 containing the V1V2 or V3 loops (CAP210 V1V2 and CAP210 V3 ), and we used SPR assays to assay binding of these proteins to immobilized 21c Fab in the presence of sCD4 or sCD4 K75T (Fig. 5e) . Binding of CAP210 V3 and core CAP210 were virtually identical (data not shown), suggesting no role for the V3 loop in restricting binding of 21c to CAP210 plus sCD4. We observed distinct differences, however, for binding of sCD4 plus 21c Fab to CAP210 V1V2 compared with binding to core CAP210 (Fig. 5e) : the on-rate was slower by over three orders of magnitude (k on = 2.0 × 10 4 M -1 sec -1 versus 2.6 × 10 7 M -1 sec -1 for CAP210 V1V2 and core CAP210, respectively), but the overall affinity was 17-fold higher for binding of 21c Fab plus sCD4 to CAP210 V1V2 (K D = 92 nM) than to core CAP210 (K D = 1.6 µM). The interaction with CAP210 V1V2 was abrogated when we used sCD4 K75T instead of sCD4 (Fig. 5e) . We saw similar effects when comparing binding of 21c Fab plus sCD4 or sCD4 K75T to core UC1 versus a V1V2-containing UC1 (UC1 full-length ); that is, the on-rate for 21c plus sCD4 binding was slower for UC1 full-length than for core UC1, but the affinity was higher, and addition of sCD4 K75T instead of sCD4 diminished the interaction (Fig. 5e) . That affinities increase for V1V2-including gp120s implies that 21c is stabilized on gp120 by forming contacts with V1V2. The slower association kinetics for forming a gp120-sCD4-21c complex in the presence of V1V2 are consistent with a model in which there is an equilibrium between multiple V1V2 conformations, with one conformation imparting stabilizing contacts with 21c after CD4 binds and other conformations sterically inhibiting binding.
DISCUSSION
The 21c bimolecular epitope suggests anti-CD4 autoreactivity
The discovery of an interaction between the 21c Fab and sCD4 suggests the potential for autoreactivity by 21c IgG, correlating with reports that autoantibodies against CD4 are found in 10-15% of HIV-infected individuals 19, 20 . Whereas the 21c epitope on CD4 is located entirely within domain 1 (Fig. 2) , most autoreactive anti-CD4 antibodies target the two membrane-proximal domains of CD4 (domains 3 and 4 (ref. 21)), which would be distant from a bound gp120), suggesting that the most common class of autoreactive anti-CD4 antibodies do not also target gp120. The bimolecular nature of the 21c epitope is reminiscent of the reactivity of other potentially autoreactive anti-HIV antibodies: the 4E10 and 2F5 broadly neutralizing antibodies, which bind lipids in addition a r t i c l e s but it was of higher quality at protein interfaces (Supplementary Fig. 3a) . The 21c Fab heavy chain portion of the model includes the same number of residues as in the free 21c structure, and the light chain includes all but the N-and C-terminal residues. sCD4 is missing one residue at the N terminus and 16 residues at the C terminus including the 6×His tag. Disordered residues in the CAP210 structure are indicated in Supplementary Figure 1 . 97.0%, 1.3% and 1.7% of the residues were in the favored, allowed and disallowed regions, respectively, of the Ramachandran plot.
We used AreaIMol in CCP4 (ref. 36 ) and a 1.4-Å probe for calculated buried surface areas and PyMol 40 for superposition calculations and molecular representations.
SPR binding experiments.
We evaluated interactions between 21c Fab, gp120 and sCD4 using a Biacore T100 instrument (GE Healthcare). We covalently immobilized purified 21c Fab (0.5 µM) to three of the four flow cells on a CM5 sensor chip (Biacore) in 10 mM acetate, pH 5.5, using standard primary amine coupling chemistry at three different densities: 250, 500, and 1,000 resonance units. We mock-coupled the fourth flow cell using buffer to serve as a blank. We performed measurements at 25 °C in 20 mM HEPES, pH 7.0, 150 mM NaCl and 0.005% (v/v) surfactant P20 and regenerated sensor chips using 10 mM glycine, pH 2.5. In some experiments, we injected a dilution series of sCD4, sCD4 K75T or CAP210 gp120 and allowed the reactions to closely approach or reach equilibrium. We derived a lower estimate for the equilibrium dissociation constant (K D ) for the 21c-sCD4 interaction by nonlinear regression analysis of a plot of the equilibrium binding response (R eq ) versus the log injected protein concentration using a 1:1 binding model (Fig. 5c) . In other experiments (Fig. 5d,e) , we injected a dilution series of a gp120 incubated with 2 µM sCD4 or sCD4 K75T at a flow rate of 90 µl min -1 and monitored the association and dissociation phases to derive kinetic constants. After subtracting the signal from the mock-coupled flow cell, we globally fit the kinetic data to a 1:1 binding model (Biacore evaluation software) to derive on-and off-rate constants, which were used to calculate the affinity as K D = k off / k on . We confirmed the low affinity for the CAP210 plus sCD4 interaction with 21c Fab (K D = 1.6 µM; Fig. 5d ) by nonlinear regression analysis of an R eq versus log injected protein concentration plot in which the highest concentration of injected CAP210 was 10 µM (data not shown).
